Received Aug 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Z007212 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | — | — |
No additional AE; HCP calling to report an AE regarding the PROQUAD vaccine. HCP reported that a 39 year old patient inadvertently received the PROQUAD and VARIVAX vaccines concomitantly. HCP reported that the patient was supposed to receive the MMR II and VARIVAX vac; Information has been received from Business Partner/CRO on 19-Aug-2025. This spontaneous report was received from a/an Nurse and refers to a(n) 39-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Aug-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z007212, expiration date: 05-Oct-2026), dose number 1,. On 19-Aug-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX UPGRADE),, dose number 1, (lot # and expiration date were not reported). On 19-Aug-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported). The patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), for the treatment of prophylaxis. The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX UPGRADE), for the treatment of prophylaxis. On 19-Aug-2025, the patient experienced HCP calling to report an AE regarding the PROQUAD vaccine. HCP reported that a 39 year old patient inadvertently received the PROQUAD and VARIVAX vaccines concomitantly. HCP reported that the patient was supposed to receive the MMR II and VARIVAX vac. On an unknown date, the patient experienced No additional AE. At the reporting time, the outcome of HCP calling to report an AE regarding the PROQUAD vaccine. HCP reported that a 39 year old patient inadvertently received the PROQUAD and VARIVAX vaccines concomitantly. HCP reported that the patient was supposed to receive the MMR II and VARIVAX vac and No additional AE was unknown. The action taken with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live. nVaricella Virus Vaccine Live (Oka-Merck) and sterile diluent was reported as not applicable.
Sterile diluent